The results of immunohistochemical staining of Beclin-1 and LC3B were separately analyzed to determine the relationship of protein expression with clinicopathological parameters of astrocytoma patients, such as age, gender, tumor grade, resistance to radiation- or chemotherapy, and KPS scale. This evidence concerns the gene BECN1 and astrocytoma (excluding glioblastoma).